Polymerase chain reaction (PCR) tests were the first available for spotting the coronavirus. They work by detecting the virus’s genetic material, and are very accurate. Then came rapid tests, also ...

Polymerase chain reaction (PCR) and rapid (antigen) tests for COVID-19 both involve taking a swab. Results for a PCR test take longer, as it needs to go to a laboratory. It is more costly but tends to ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

“It's well known that sensitivity is a major driver of commercial success and value for point-of-care tests,” said Jim Kadushin, Genisphere's Chief Operating Officer. “Genisphere's new process for ...

During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

A private school has announced it will use lateral flow tests for the coronavirus for its pupils and staff. Saltus is one of several private schools to offer the tests, which will be administered at ...

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care ("POC") diagnostic tests for infectious ...

MANCHESTER/LONDON, England, Oct 6 (Reuters) - Britain is aiming early next year to be ready to start charging for some previously free COVID-19 tests, two sources close to the health service said, a ...

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, ...